Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: a mini-review and case report
Chinese Clinical Oncology · 2023
DOI: 10.21037/cco-23-55 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Clinical Oncology, 2023. Verfasst von Doreen Goh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: The abscopal effect, in which radiation induces a systemic anti-tumour immune response, has been demonstrated with radiotherapy. Immunotherapy boosts the abscopal effect by facilitating the immune response to radiation. Radiotherapy and programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) blockade has resulted in the boosted abscopal effect in solid cancers, but its role in anaplastic thyroid cancer (ATC) is unknown. In this mini-review, we describe the abscopal effect and summarise its proposed underlying mechanisms. We then present a potential case of boosted abscopal effect in ATC. CASE DESCRIPTION: In our case presentation, we describe a 51-year-old female who presented with 3 weeks of rapidly enlarging thyroid mass. Examination revealed a 3-cm thyroid nodule which was Bethesda V on fine needle aspiration cytology (FNAC). Intraoperatively, there was a gross extrathyroidal extension into the cricoid cartilage. After total thyroidectomy, post-operative histopathology showed widely invasive follicular thyroid cancer with anaplastic transformation (>50%). Immunohistochemistry showed high PD-L1 expression [combined positive score (CPS) >70%]. Due to residual cricoid cartilage disease and several peri-hilar and lung metastases on positron emission tomography-computed tomography (PET-CT) scan, she underwent post-operative palliative radiotherapy and pembrolizumab. After two cycles of pembrolizumab, repeat PET-CT scan showed complete response (CR) of local and distant disease. She remained well for 32 months, before recent discovery of a right mandible bony metastasis planned for radiotherapy. CONCLUSIONS: This case demonstrates exceptional response to radiotherapy and anti-PD-1 immunotherapy in ATC, potentially illustrating the first known abscopal effect in ATC with this treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
- Department of Otolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore, Singapore.
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
- Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore; Precision Radiotherapeutics and Oncology Programme, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Sing…
Zitieren
APA
Goh, D., Lim, K. H., Sudirman, S. R. B., Ang, M. K., Chua, M. L. K., & Lim, C. M. (2023). Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: a mini-review and case report. Chinese Clinical Oncology. https://doi.org/10.21037/cco-23-55
Vancouver
Goh D, Lim KH, Sudirman SRB, Ang MK, Chua MLK, Lim CM. Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: a mini-review and case report. Chinese Clinical Oncology. 2023. doi:10.21037/cco-23-55
BibTeX
@article{Goh2023,
author = {Goh, Doreen and Lim, Kok Hing and Sudirman, Siti Radhziah Binte and Ang, Mei-Kim and Chua, Melvin Lee Kiang and Lim, Chwee Ming},
title = {Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: a mini-review and case report},
journal = {Chinese Clinical Oncology},
year = {2023},
doi = {10.21037/cco-23-55}
}
EUVIMED